BioInformatics, LLC New Market Report - Next Generation Sequencing

Oct 18, 2011, 11:23 ET from BioInformatics, LLC

ARLINGTON, Va., Oct. 18, 2011 /PRNewswire/ -- BioInformatics, LLC announces the release of their newest market report:

The Global Outlook for Next Generation Sequencing:  Usage, Preferences and Budgets (11-003)

This worldwide study of the academic and pharma/biotech sectors provides a market analysis of next generation sequencing (NGS) and an assessment of the brand equity and brand positioning of companies providing NGS instrumentation and consumables.  To better understand the current market for NGS technologies, the report includes an in-depth exploration of NGS technologies currently deployed, workflow and types of applications.  

The following suppliers' products were provided as some of the answer choices in the survey:

Agilent Technologies
Fluidigm
Helicos Biosciences
Idaho Technology, Inc.
Illumina
Invitrogen (Life Technologies)
Ion Torrent (Life Technologies)
Life Technologies/SOLiD Sequencing
NuGEN
Pacific Biosciences
RainDance Technologies
Roche/NimbleGen

"Beyond the traditional sampling of genome content, a diversity of applications are emerging for next generation sequencing technologies, firmly securing its place at the forefront of scientific discovery," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that: "The market analysis presented in this report will provide life science suppliers with the guidance they need to keep up with such a rapidly advancing field."

To learn more about this report, a complimentary Executive Summary is available at:
http://www.gene2drug.com/index.php?page=reports&id=220

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 66,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:

Mary Follin
Manager, Marketing/Sales
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA  22201
703.778.3080 x13 (phone)
m.follin@gene2drug.com

http://www.gene2drug.com/

SOURCE BioInformatics, LLC



RELATED LINKS

http://www.gene2drug.com